Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features.

Helena Ferreira Leal, Jailton Azevedo, Giulyana Evelyn Oliveira Silva, Angelica Maria Lima Amorim, Larissa Rangel Cabral de Roma, Ana Carolina Palmeira Arraes, Edilane Lins Gouveia, Mitermayer Galvão Reis, Ana Verena Mendes, Marcio de Oliveira Silva, Maria Goreth Barberino, Ianick Souto Martins, Joice Neves Reis
Author Information
  1. Helena Ferreira Leal: Laboratory of Pathology and Molecular Biology (LPBM), Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Candeal, Salvador, Bahia, 40296-710, Brazil.
  2. Jailton Azevedo: Laboratory of Pathology and Molecular Biology (LPBM), Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Candeal, Salvador, Bahia, 40296-710, Brazil.
  3. Giulyana Evelyn Oliveira Silva: Laboratory of Research on Clinical Microbiology (LPMC), School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, 40170-115, Brazil.
  4. Angelica Maria Lima Amorim: Laboratory of Research on Clinical Microbiology (LPMC), School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, 40170-115, Brazil.
  5. Larissa Rangel Cabral de Roma: Laboratory of Research on Clinical Microbiology (LPMC), School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, 40170-115, Brazil.
  6. Ana Carolina Palmeira Arraes: São Rafael Hospital, São Marcos, Salvador, Bahia, 41253-190, Brazil.
  7. Edilane Lins Gouveia: Bahia Hospital, Pituba, Salvador, Bahia, 40280-000, Brazil.
  8. Mitermayer Galvão Reis: Laboratory of Pathology and Molecular Biology (LPBM), Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Candeal, Salvador, Bahia, 40296-710, Brazil.
  9. Ana Verena Mendes: São Rafael Hospital, São Marcos, Salvador, Bahia, 41253-190, Brazil.
  10. Marcio de Oliveira Silva: São Rafael Hospital, São Marcos, Salvador, Bahia, 41253-190, Brazil.
  11. Maria Goreth Barberino: São Rafael Hospital, São Marcos, Salvador, Bahia, 41253-190, Brazil.
  12. Ianick Souto Martins: Faculty of Medicine, Fluminense Federal University Downtown, 24033-900, Niterói, Rio de Janeiro, Brazil.
  13. Joice Neves Reis: Laboratory of Research on Clinical Microbiology (LPMC), School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, 40170-115, Brazil. joice@ufba.br. ORCID

Abstract

BACKGROUND: Bloodstream infections (BSI) are associated with high morbidity and mortality. This scenario worsens with the emergence of drug-resistant pathogens, resulting in infections which are difficult to treat or even untreatable with conventional antimicrobials. The aim of this study is to describe the epidemiological aspects of BSI caused by multiresistant gram-negative bacilli (MDR-GNB).
METHODS: We conducted a laboratory-based surveillance for gram-negative bacteremia over a 1-year period. The bacterial isolates were identified by MALDI-TOF/MS and the antimicrobial susceptibility testing was performed by VITEK®2. Resistance genes were identified through PCR assays.
RESULTS: Of the 143 patients, 28.7% had infections caused by MDR-GNB. The risk factors for MDR bacteremia were male sex, age ≥ 60, previous antimicrobial use, liver disease and bacteremia caused by K. pneumoniae. K. pneumoniae was the most frequently observed causative agent and had the highest resistance level. Regarding the resistance determinants, SHV, TEM, OXA-1-like and CTX-M-gp1 were predominant enzymatic variants, whereas CTX-M-gp9, CTX-M-gp2, KPC, VIM, GES, OXA-48-like, NDM and OXA-23-like were considered emerging enzymes.
CONCLUSIONS: Here we demonstrate that clinically relevant antibiotic resistance genes are prevalent in this setting. We hope our findings support the development of intervention measures by policy makers and healthcare professionals to face antibiotic resistance.

Keywords

References

  1. Int J Antimicrob Agents. 1999 Jan;11(1):7-12 [PMID: 10075272]
  2. J Antimicrob Chemother. 2002 Dec;50(6):775-7 [PMID: 12460994]
  3. Intensive Care Med. 2003 Apr;29(4):530-8 [PMID: 12664219]
  4. Chest. 1992 Jun;101(6):1644-55 [PMID: 1303622]
  5. Clin Infect Dis. 2005 Jun 15;40(12):1792-8 [PMID: 15909268]
  6. JAMA. 2007 Oct 17;298(15):1763-71 [PMID: 17940231]
  7. J Chemother. 2008 Apr;20(2):219-24 [PMID: 18467249]
  8. Chest. 2009 Nov;136(5):1237-1248 [PMID: 19696123]
  9. J Antimicrob Chemother. 2010 Mar;65(3):490-5 [PMID: 20071363]
  10. J Clin Microbiol. 2011 May;49(5):1866-71 [PMID: 21411591]
  11. Clin Microbiol Infect. 2012 Mar;18(3):268-81 [PMID: 21793988]
  12. Expert Rev Anti Infect Ther. 2011 Aug;9(8):653-79 [PMID: 21819331]
  13. J Hepatol. 2012 Apr;56(4):756-7 [PMID: 22230869]
  14. Indian J Med Sci. 2010 Nov;64(11):485-92 [PMID: 23051940]
  15. BMC Infect Dis. 2012 Dec 26;12:375 [PMID: 23267668]
  16. Commun Dis Intell Q Rep. 2012 Dec 31;36(4):E333-41 [PMID: 23330707]
  17. J Antimicrob Chemother. 2013 Oct;68(10):2181-2 [PMID: 23743087]
  18. PLoS One. 2013 Jul 04;8(7):e68144 [PMID: 23861860]
  19. PLoS One. 2014 Jan 27;9(1):e87315 [PMID: 24475269]
  20. Drug Resist Updat. 2014 Apr;17(1-2):24-36 [PMID: 24618111]
  21. PLoS One. 2014 Mar 18;9(3):e91713 [PMID: 24643200]
  22. Am J Infect Control. 2014 Jun;42(6):626-31 [PMID: 24725516]
  23. JAMA. 2014 Jul 2;312(1):90-2 [PMID: 24838355]
  24. Clin Microbiol Rev. 2014 Oct;27(4):647-64 [PMID: 25278570]
  25. Minerva Anestesiol. 2015 Sep;81(9):980-8 [PMID: 25411769]
  26. PLoS One. 2015 Mar 23;10(3):e0123690 [PMID: 25798828]
  27. Lancet Infect Dis. 2015 May;15(5):581-614 [PMID: 25932591]
  28. Diagn Microbiol Infect Dis. 2015 Aug;82(4):326-30 [PMID: 25935630]
  29. Clin Microbiol Rev. 2016 Jan;29(1):59-103 [PMID: 26598385]
  30. Pediatr Infect Dis J. 2016 May;35(5):507-10 [PMID: 26766146]
  31. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  32. Antibiotics (Basel). 2015 Oct 30;4(4):467-79 [PMID: 27025636]
  33. PLoS One. 2016 Apr 22;11(4):e0154092 [PMID: 27104910]
  34. Braz J Microbiol. 2016 Dec;47 Suppl 1:31-37 [PMID: 27825605]
  35. Lancet Infect Dis. 2017 Feb;17(2):e56-e63 [PMID: 27866945]
  36. Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):537-544 [PMID: 27885442]
  37. Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297 [PMID: 27915487]
  38. Intensive Care Med. 2017 Mar;43(3):304-377 [PMID: 28101605]
  39. Infect Control Hosp Epidemiol. 2017 May;38(5):606-609 [PMID: 28202087]
  40. Antimicrob Agents Chemother. 2017 May 24;61(6): [PMID: 28373189]
  41. Braz J Infect Dis. 2017 May - Jun;21(3):339-342 [PMID: 28399425]
  42. Am J Infect Control. 2017 May 1;45(5):512-518 [PMID: 28456321]
  43. Braz J Infect Dis. 2018 Jan - Feb;22(1):47-50 [PMID: 29144958]
  44. J Chronic Dis. 1987;40(5):373-83 [PMID: 3558716]

Grants

  1. PP-SUS 0024/2014/Fundação de Amparo à Pesquisa do Estado da Bahia
  2. CNPq 465718/2014-0/Instituto Nacional de Pesquisa em Resistência Antimicrobiana

MeSH Term

Adolescent
Adult
Anti-Bacterial Agents
Bacteremia
Brazil
Child
Child, Preschool
Drug Resistance, Multiple, Bacterial
Female
Gram-Negative Bacteria
Gram-Negative Bacterial Infections
Humans
Infant
Infant, Newborn
Klebsiella Infections
Male
Microbial Sensitivity Tests
Middle Aged
Prevalence

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0resistanceinfectionscausedgram-negativebacteremiaBloodstreamBSIepidemiologicalMDR-GNBidentifiedantimicrobialgenesKpneumoniaeantibioticBACKGROUND:associatedhighmorbiditymortalityscenarioworsensemergencedrug-resistantpathogensresultingdifficulttreatevenuntreatableconventionalantimicrobialsaimstudydescribeaspectsmultiresistantbacilliMETHODS:conductedlaboratory-basedsurveillance1-yearperiodbacterialisolatesMALDI-TOF/MSsusceptibilitytestingperformedVITEK®2ResistancePCRassaysRESULTS:143patients287%riskfactorsMDRmalesexage ≥ 60previoususeliverdiseasefrequentlyobservedcausativeagenthighestlevelRegardingdeterminantsSHVTEMOXA-1-likeCTX-M-gp1predominantenzymaticvariantswhereasCTX-M-gp9CTX-M-gp2KPCVIMGESOXA-48-likeNDMOXA-23-likeconsideredemergingenzymesCONCLUSIONS:demonstrateclinicallyrelevantprevalentsettinghopefindingssupportdevelopmentinterventionmeasurespolicymakershealthcareprofessionalsfacemultidrug-resistantbacteria:clinicalmicrobiologicalfeaturesAntibioticBacteremiaGram-negativebacteria

Similar Articles

Cited By